The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
MDMA enhances emotional empathy and prosocial behavior
Open accessAbstract
3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') releases serotonin and norepinephrine. MDMA is reported to produce empathogenic and prosocial feelings. It is unknown whether MDMA in fact alters empathic concern and prosocial behavior. We investigated the acute effects of MDMA using the Multifaceted Empathy Test (MET), dynamic Face Emotion Recognition Task (FERT) and Social Value Orientation (SVO) test. We also assessed effects of MDMA on plasma levels of hormones involved in social behavior using a placebo-controlled, double-blind, random-order, cross-over design in 32 healthy volunteers (16 women). MDMA enhanced explicit and implicit emotional empathy in the MET and increased prosocial behavior in the SVO test in men. MDMA did not alter cognitive empathy in the MET but impaired the identification of negative emotions, including fearful, angry and sad faces, in the FERT, particularly in women. MDMA increased plasma levels of cortisol and prolactin, which are markers of serotonergic and noradrenergic activity, and of oxytocin, which has been associated with prosocial behavior. In summary, MDMA sex-specifically altered the recognition of emotions, emotional empathy and prosociality. These effects likely enhance sociability when MDMA is used recreationally and may be useful when MDMA is administered in conjunction with psychotherapy in patients with social dysfunction or post-traumatic stress disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MDMA primarily stimulates the release of serotonin (5-HT), norepinephrine (NE), and dopamine (DA), while also promoting oxytocin release.”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Kuypers (157) and Hysek et al. (81) found that MDMA enhances self-compassion and empathy and facilitates deeper self-reflection and interpersonal engagement, which may promote self-efficacy in these patients.”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, its prosocial effects - such as increased sociability and decreased social sensitivity - have been linked to improved therapeutic engagement (81, 88), making patients less guarded and more willing to explore painful emotional material.”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the tendency for MDMA to strengthen emotional responses to positive social stimuli (44, 122) is likely to make therapists' responses of compassion and warmth more salient at a visceral level.”
From MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder (2021) · cites this paper as [122]
In the citing paper
“Entactogens as well as hallucinogens have been shown to successfully modulate social processing in rigorous scientific studies (10–12).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“Furthermore, MDMA (125 mg) increased the subjective experience of being close to others and trusting others by approximately 25% during peak effects (10, 39).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“In line with this, MDMA (75, 100, & 125 mg), GHB (20 mg/kg), and psilocybin (0.215 mg/kg) did not affect cognitive empathy on the MET (10, 12, 51–53, 62).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“Additionally, a 125 mg dose of MDMA impaired the identification of fearful faces (39) and of fearful, angry, and sad faces, particularly in women, in a second study (10).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“In two studies this increase was particularly pronounced in response to positive stimuli and in male participants (10, 51).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“One hundred twenty-five milligrams as well as 75 mg MDMA increased emotional empathy (10, 51, 52).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“No effect was found for female participants, potentially because they already showed high altruistic behavior following placebo administration (10).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“male participants made more altruistic choices after the administration of 125 mg MDMA (10).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“It releases 5-HT, NE, and, to a lower extent, DA from nerve terminals via action on monoamine transporters, and increases plasma levels of oxytocin, prolactin, and cortisol (10).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“For example, increases in emotional empathy, impaired identification of negative emotions, enhanced decoding of positive facial expressions, and increased altruistic choices after MDMA administration were not related to oxytocin plasma levels or other neuroendocrine effects (10, 51, 52, 54).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“Interestingly, these social functions were not influenced by acute administration of MDMA in controlled studies (10, 51, 52).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“LSD and MDMA have shown some dose-dependent effects on empathy and altruistic behavior (10, 33, 51), indicating that robust modulations are measurable at doses of 100 mg MDMA/100µg LSD and above.”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“It has been shown that MDMA enhances emotional empathy predominantly in male participants (10).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [10]
In the citing paper
“Additionally, the acute prosocial and interpersonal effects of MDMA25,29 may support the quality of the therapeutic alliance, a potentially important factor relating to PTSD treatment adherence30 and outcome31.”
From MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study (2021) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring individual differences in empathy: Evidence for a multidimensional approach.
Davis, M. H. (1983) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.44.1.113 · Cited by 10,272
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Self-citationOxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639
Blair, R. J. R. (2005) · Consciousness and Cognition · doi:10.1016/j.concog.2005.06.004 · Cited by 1,365
Oxytocin improves “mind-reading” in humans
Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.015 · Cited by 1,298
Self-citationAssay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin
Morgenthaler, N. G., Struck, J., Alonso, C., & Bergmann, A. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.060038 · Cited by 1,166
Measuring Social Value OrientationPreprint
Murphy, R. O., Ackermann, K., & Handgraaf, M. (2011) · Social Science Research Network · doi:10.2139/ssrn.1804189 · Cited by 1,099
The human amygdala and the emotional evaluation of sensory stimuli
Zald, D. H. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00248-5 · Cited by 1,062
Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella, A. J., Einfeld, S. L., Gray, K. M., Rinehart, N. J., Tonge, B. J., Lambert, T. J., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.020 · Cited by 962
Dziobek, I., Rogers, K., Fleck, S., Bahnemann, M., Heekeren, H. R., Wolf, O. T., & Convit, A. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-007-0486-x · Cited by 951
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1037//0022-3514.44.1.113 · DOI · Paper page
Cited by
Sorted by citations
Items 301–355 of 355
The use of psychoactive substances in the treatment of mental disorders
Karaś-Ruszczyk, K., Groblińska, K., Szczygieł, K., & Samochowiec, J. (2021) · Alcoholism and Drug Addiction · doi:10.5114/ain.2021.111791
Effects of Amphetamine-Type Stimulants on the Metabolome
Steuer, A. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_122-1
The good, the bad, and the intoxicated
Mason, N. L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210608nm
de Oliveira‐Souza, R., Moll, J., & Zahn, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.24019-4
Steinhart, E. C. (2022) · Palgrave frontiers in philosophy of religion · doi:10.1007/978-3-031-17752-1_8
LSD et MDMA en combinaison (Candy Flip)
Poloméni, P. (2023) · Psychotropes · doi:10.3917/psyt.291.0089
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.002.0004
May, J. (2023) · Neuroethics · doi:10.1093/oso/9780197648087.002.0006
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0010
May, J. (2023) · Neuroethics · doi:10.1093/oso/9780197648087.002.0007
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0004
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.002.0008
May, J. (2023) · Neuroethics · doi:10.1093/oso/9780197648087.002.0003
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0001
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0009
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0003
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0002
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0006
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0005
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0008 · Cited by 1
May, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197648087.003.0007
May, J. (2023) · Neuroethics · doi:10.1093/oso/9780197648087.002.0010
Neurociências desvendando as bases neurais da empatia: conexão do leitor nas obras literárias
de Moura, R. M. B. L., & Franz, M. J. (2023) · doi:10.22533/at.ed.852231109
MDMA enhances early visual processing for salient socio-emotional stimuli.Preprint
Haggarty, C. J., Bershad, A. K., Kumar, M., Lee, R., & de Wit, H. (2024) · doi:10.22541/au.171117634.48543663/v1
The Conceptual Framework for the Therapeutic Approach used in Phase 3 Trials of MDMA-AT for PTSDPreprint
O’Donnell, K. C., Alpert, M., Okano, L., Nicholas, C. R. N., Thomas, C., Poulter, B., Mithoefer, A. T., Mithoefer, M. C., & Marcela Ot’alora, G. (2024) · doi:10.31219/osf.io/gey78
MDMA modulates human sensorimotor cortical pathways during gentle touch
Molla, H. M., Novembre, G., Bershad, A. K., Handlin, L., Perini, I., de Wit, H., & Morrison, I. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00316
Applications of MDMA in Modern Medicine - A Literature Review
Podlasiewicz, W., Siudziński, P., Łyko, M., Skoczylas, A., Kurasz, J., Maj, W., Tomaszewska, W., Pala, K., Dudziak, P., Nowak, A., et al. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.77.56620
Exploring the therapeutic convergence of meditation, psychedelics, and MDMA
Dines, J. T. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00435 · Cited by 2
Waldman, E. D., Romanko, M., Skellie, M., & Bates, M. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197760864.003.0003
Lu, M., Tucci, V., Parakh, N. D., Pereira, S. M., Leda, M., Mattina, G. F., Nayar, R., Thomas, Z., Pazmino‐Canizares, J., Ladha, K. S., et al. (2025) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-025-03031-0
Therapeutic Potential of Psychedelics: Mechanisms, Applications, and Challenges
Castaño-Perez, G., & Castaño-Ocampo, S. I. (2025) · Pharmaceutical science. · doi:10.5772/intechopen.1011560
Véliz‐García, Ó., & Domic‐Siede, M. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00454
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25876232
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25876328
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26723801
Linking Substance Use and Schizophrenia
Mutlu, E., Özden, H. C., & Ertuğrul, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_179
Harkhoe, M. A., Offringa, T. M., & Vermetten, E. H. G. J. M. (2025) · Journal of Eating Disorders · doi:10.1186/s40337-025-01409-5
Mejia, S. H., Ashwinee, A., & Aldaker, R. (2026) · Cureus · doi:10.7759/cureus.101526
Felsch, K. A., & Siegel, J. A. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116098 · Cited by 1
Santé mentale et psychédéliques : révolution ou promesse utopique ?
Duguey, A. L., Fauvel, B., & Bioy, A. (2025) · Perspectives Psy · doi:10.1051/ppsy/2025055
Gaughan, S. J., Sevelius, J. M., Lancelotta, R., Anderson, K. D., Davis, A. K., Wootton, A. R., Krantz, D., & James, J. E. (2026) · Psychedelics · doi:10.1016/j.psyche.2026.100011
Gerrans, P., McGovern, H. T., Hohwy, J., & Oestreich, L. (2026) · European Journal of Psychotraumatology · doi:10.1080/20008066.2026.2631358 · Cited by 1
Shared effects of the opioid antagonist naltrexone on first-hand and empathic pain
Braunstein, J., Rütgen, M., & Lamm, C. (2026) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsag018
Biomarkers for complex post-traumatic stress disorder: translational and evolutionary perspectives
Rajkumar, R. P. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1786811
Sáez‐Briones, P., Silva-Rodríguez, A., Morales-Vidal, M., Sepúlveda-Fernández, Y., Jara-Clen, D., Castro-Choapa, M., Livacic-Rojas, P. E., Martínez-Afani, D., Cassels, B. K., Barra, R., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1779772
Low, Z. X. B. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111717 · Cited by 2
A Lacanian Exploration of Party Drug Use Through Subjects’ Discourses
Okumuş, S., Saraç, D., & HEKİMOĞLU, E. C. (2026) · Ayna Klinik Psikoloji Dergisi · doi:10.31682/ayna.1814548
Brar, P. S., Price, R. B., Ross, S., Tofighi, B., & Sarpal, D. K. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261456191
Mason, N. L., Mallaroni, P., Kuypers, K. P. C., de la Torre, R., Reckweg, J. T., Preller, K. H., & Ramaekers, J. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742704
Self-citationMorland, L. A., Khalifian, C. E., Perivoliotis, D., Chargin, B. E., Alam, A., Wachsman, T. R., Ramanathan, D., Bismark, A. W., Stauffer, C., Wagner, A. C., et al. (2026) · Journal of Traumatic Stress · doi:10.1002/jts.70126
Theory of Mind in Psychoactive Substance Users: A Systematic Literature Review and Meta-analysis
Neto, J. V. D. L., & Osório, F. D. L. (2026) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-026-01717-0
Rullo, L., Losapio, L. M., Mrizak, H., Morosini, C., Nasuti, C., Ubaldi, M., Mangione, P., Lacorte, A., Coluzzi, F., Soverchia, L., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111187
Simon, G., Hopper, J. W., Cherniak, A. D., Cassidy, E. K., Skragge, M., & Granqvist, P. (2026) · Neuroethics · doi:10.1007/s12152-026-09672-2
Psychedelic Drug Use and Romantic Relationship Functioning
Hutto, R., Amada, N. M., & Shane, J. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2743939
Frick, A., Blest‐Hopley, G., Grin, M., Erritzøe, D., Nutt, D., & Carhart-Harris, R. L. (2026) · Psychopharmacology · doi:10.21203/rs.3.rs-9880403/v1
Metadata
- Authors
- Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E.
- Affiliations
- University of Vienna (AT)
- ORCID
- Venue
- Social Cognitive and Affective Neuroscience
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-04
- Volume
- 9
- Issue
- 11
- Pages
- 1645-1652
- ISSN
- 1749-5016 (ISSN-L)
- 1749-5024
- PMC
- PMC4221206
- OpenAlex
- W2165032621
- Cited by
- 356
- References
- 58
- Citations by year
- 2026: 24 · 2025: 38 · 2024: 37 · 2023: 58 · 2022: 27 · 2021: 31 · 2020: 17 · 2019: 18 · 2018: 23 · 2017: 26 · 2016: 25 · 2015: 18 · 2014: 14
- FWCI
- 21.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Social Cognitive and Affective Neuroscience (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion, other-oa)
- Research Bank (Australian Catholic University) (submittedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- National Science Foundation
- Universität Basel
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (138481, 144996, 320030)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- MDMA, ecstasy, empathic concern, affective empathy, prosocial behavior, sex differences, facial emotion recognition, social value orientation, cortisol, prolactin, oxytocin, serotonin, norepinephrine, acute drug effects, sociability
- MeSH terms
- Adult, Analysis of Variance, Double-Blind Method, Emotions, Empathy, Face, Female, Glycopeptides, Hallucinogens, Humans, Interpersonal Relations, Male, Oxytocin, Pattern Recognition, Visual, Social Behavior, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine, Young Adult, Visual Analog Scale
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
